Possibilities of therapy for neuromyelitis optica spectrum disorders

Neuromyelitis optica spectrum disorders are rare chronic autoimmune inflammatory demyelinating diseases of the central nervous system. Considering that the increase in neurological deficit in neuromyelitis optica spectrum disorders is mainly due to repeated exacerbations, the goals of pharmacotherap...

Full description

Bibliographic Details
Main Author: E. S. Novikova
Format: Article
Language:Russian
Published: ABV-press 2022-01-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/386
_version_ 1797874430786928640
author E. S. Novikova
author_facet E. S. Novikova
author_sort E. S. Novikova
collection DOAJ
description Neuromyelitis optica spectrum disorders are rare chronic autoimmune inflammatory demyelinating diseases of the central nervous system. Considering that the increase in neurological deficit in neuromyelitis optica spectrum disorders is mainly due to repeated exacerbations, the goals of pharmacotherapy are represented by the relief of relapses and the prevention of their development. Information about indications for therapy and side effects is necessary to identify the benefits and risks for patients with neuromyelitis optica spectrum disorders in each individual case.
first_indexed 2024-04-10T01:31:58Z
format Article
id doaj.art-c58b86c18ded405bba5ab5751ab6ebae
institution Directory Open Access Journal
issn 2073-8803
2412-9178
language Russian
last_indexed 2024-04-10T01:31:58Z
publishDate 2022-01-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj.art-c58b86c18ded405bba5ab5751ab6ebae2023-03-13T09:30:13ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782022-01-01164495810.17650/2073-8803-2021-16-4-49-58261Possibilities of therapy for neuromyelitis optica spectrum disordersE. S. Novikova0ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»Neuromyelitis optica spectrum disorders are rare chronic autoimmune inflammatory demyelinating diseases of the central nervous system. Considering that the increase in neurological deficit in neuromyelitis optica spectrum disorders is mainly due to repeated exacerbations, the goals of pharmacotherapy are represented by the relief of relapses and the prevention of their development. Information about indications for therapy and side effects is necessary to identify the benefits and risks for patients with neuromyelitis optica spectrum disorders in each individual case.https://rjdn.abvpress.ru/jour/article/view/386заболевания спектра оптиконевромиелитаантитела к миелинолигодендроцитарному гликопротеинуантитела к аквапорину 4интерлейкин 6анти-в-клеточная терапия
spellingShingle E. S. Novikova
Possibilities of therapy for neuromyelitis optica spectrum disorders
Русский журнал детской неврологии
заболевания спектра оптиконевромиелита
антитела к миелинолигодендроцитарному гликопротеину
антитела к аквапорину 4
интерлейкин 6
анти-в-клеточная терапия
title Possibilities of therapy for neuromyelitis optica spectrum disorders
title_full Possibilities of therapy for neuromyelitis optica spectrum disorders
title_fullStr Possibilities of therapy for neuromyelitis optica spectrum disorders
title_full_unstemmed Possibilities of therapy for neuromyelitis optica spectrum disorders
title_short Possibilities of therapy for neuromyelitis optica spectrum disorders
title_sort possibilities of therapy for neuromyelitis optica spectrum disorders
topic заболевания спектра оптиконевромиелита
антитела к миелинолигодендроцитарному гликопротеину
антитела к аквапорину 4
интерлейкин 6
анти-в-клеточная терапия
url https://rjdn.abvpress.ru/jour/article/view/386
work_keys_str_mv AT esnovikova possibilitiesoftherapyforneuromyelitisopticaspectrumdisorders